International Biotechnology Trust, based in London, focuses on the fast-growing biotechnology sector through an actively managed, diversified fund. The firm invests in a wide-ranging portfolio of global quoted biotechnology stocks and includes a small proportion of carefully selected unquoted investments. Their investment strategy spans various stages, leveraging the expertise of fund managers at SV Health Investors who collectively have over 60 years of experience in the biotech sector.
Notable portfolio companies include eBioinformatics and Sutro Biopharma. The firm's key partners are scientifically and medically trained, bringing deep industry knowledge to their investment decisions. International Biotechnology Trust's investment philosophy emphasizes a diversified approach to mitigate risks while capitalizing on high-growth opportunities within the biotech sector. They offer unique value-add services through their extensive industry experience and network, enhancing the growth potential of their portfolio companies.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.